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Active smoking and risk of breast cancer in
a Danish nurse cohort study
Zorana Jovanovic Andersen1*, Jeanette Therming Jørgensen1, Randi Grøn1, Elvira Vaclavik Brauner2,3
and Elsebeth Lynge1
Abstract
Background: No scientific consensus has been reached on whether active tobacco smoking causes breast cancer.
We examine the association between active smoking and breast cancer risk in Denmark, which has some of the
highest smoking and breast cancer rates in women worldwide.
Methods: We used the data from a nationwide Danish Nurse Cohort on 21,867 female nurses (age > 44 years) who
at recruitment in 1993 or 1999 reported information on smoking status, onset, duration, and intensity, as well as
breast cancer risk factors. We obtained data on incidence of breast cancer from Danish Cancer Registry until 2013,
and used Cox regression models to analyze the association between smoking and breast cancer.
Results: Of 21,831 women (mean age 53.2 years) 1162 developed breast cancer during 15.7 years of follow-up. 33.
7% of nurses were current and 30.0% former smokers at cohort baseline. Compared to never smokers, we found
increased risk of breast cancer of 18% in ever (hazard ratio and 95% confidence interval: 1.18; 1.04–1.34) and 27% in
current (1.27; 1.11–1.46) smokers. We detected a dose-response relationship with smoking intensity with the highest
breast cancer risk in women smoking >15 g/day (1.31; 1.11–1.56) or >20 pack-years (1.32; 1.12–1.55). Parous women
who smoked heavily (>10 pack-years) before first childbirth had the highest risk of breast cancer (1.58; 1.20–2.10).
Association between smoking and breast cancer was not modified by menopausal status, obesity, alcohol or
hormone therapy use, and seemed to be limited to the estrogen receptor positive breast cancer subtype.
Conclusions: Active smoking increases risk of breast cancer, with smoking before first birth being the most relevant
exposure window.
Keywords: Tobacco smoking, Active smoking, Breast cancer, Cohort
Background
Tobacco smoke is the leading cause of cancer worldwide
and contains over 4000 known carcinogenic substances.
[1] No scientific consensus has been reached on whether
active tobacco smoking causes breast cancer, despite
25 years of debate and over 150 epidemiological studies.
[2, 3] Smoking has been suggested to have an anti-
estrogenic effect [4] and should thus be expected to pro-
tect against breast cancer in post-menopausal women.
However, a meta-analysis of 53 epidemiological studies
found no impact of smoking on the risk of breast cancer.
[5] Early studies on smoking and breast cancer risk have
however been criticized for their crude definitions of
smoking and lack of information on intensity, duration,
and onset, or use of hospital based controls in case-
control studies, which may explain the null associations
reported. [5]
Recent large prospective cohort studies [6–13] with
detailed data on active smoking consistently report an
increased breast cancer risk associated with longer dur-
ation and higher intensity of smoking, and indicating
that smoking early in life, before first childbirth, is the
most relevant exposure window. [6, 7, 9, 11] Still, some
inconsistencies exist as not all recent studies linked ac-
tive smoking to breast cancer. [14, 15] The latest reports
from the International Agency for Research on Cancer
(IARC) [1] and the US Surgeon General [3] conclude
that there was suggestive, but insufficient, evidence to
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infer a causal relationship between active smoking and
breast cancer, [3] calling for more data.
In Denmark, with some of the highest smoking preva-
lence and breast cancer incidence in the world, the impact
of smoking on breast cancer has been debated due to con-
flicting results from the early Danish studies. [16, 17]
More recently, no association between smoking and breast
cancer was detected in 28,000 women from Danish Diet,
Cancer and Health cohort which formed part of the large
European Prospective investigation into Cancer and Nu-
trition (EPIC) study. [11] In the EPIC study, the observed
overall positive association between smoking and breast
cancer was driven by data from the other non-Danish
EPIC cohorts. [11] On this basis, we investigated the asso-
ciation between active smoking and breast cancer risk in
members of the Danish Nurse Cohort, which is a large,
nationwide cohort of female nurses older than 44 years.
Methods
The Danish nurse cohort
The Danish Nurse Cohort [18] was inspired by the
American Nurses’ Health Study to initially investigate
the health effects of hormone therapy (HT) in a Euro-
pean population. The cohort was initiated in 1993 by
sending a questionnaire to 23,170 female Danish nurses
(> 44 years), members of the Danish Nursing
Organization, which included 95% of all nurses in
Denmark. In total, 19,898 (86%) nurses replied, and the
cohort was reinvestigated in 1999, including an add-
itional 10,534 nurses (who turned 44 years in the period
1993–99), of whom 8833 (84%) replied. Nurses filled out
the questionnaire at recruitment on working conditions,
weight and height, lifestyle (diet, active smoking, alcohol
consumption, and leisure time physical activity), parity,
age at first birth, age of menarche and menopause, and
use of oral contraceptives (OC) and HT. We utilized base-
line information from 1993 (19,898) or 1999 (8833) for
28,731 female nurses. Using a unique identification num-
ber we linked the cohort participants to Civil Registration
System [19] to obtain vital status information at 31st
December 2012 (active, date of death or emigration).
Active tobacco smoking
Data on active tobacco smoking were obtained from the
baseline questionnaire in 1993 or 1999, and included
questions on smoking status (never/former/current),
smoking duration (years), age at smoking onset (years),
average number of cigarettes, cheerots, and cigars smoked
per day, and on smoking a pipe (yes/no) in ever smokers.
Based on this information we calculated smoking intensity
in g/day by equating a cigarette to 1 g, a cheroot to 3 g,
and a cigar to 4.5 g of tobacco, and pack-years of smoking
by multiplying the number of packs per day (1 pack = 20 g)
and the number of years smoked. We defined onset of
smoking before and after 1st birth in parous women and
age of 21 years (mean age of smoking initiation in the co-
hort) in nulliparous women. Pack-years of smoking before
1st childbirth, between 1st childbirth and menopause, and
after menopause was calculated from information on age
of smoking onset, age at 1st birth, and age at menopause
in parous postmenopausal women. No information was
collected on passive smoking in the Danish Nurse Cohort.
Breast cancer definition
We linked the records of 28,731 nurses using unique
identification number to the Danish Cancer Register
[20] to extract all cancer diagnoses until 2013. First, we
extracted data for nurses with diagnoses for any (other
than non-melanoma skin cancer) cancer before baseline
(1st April 1993 or 1st April 1999), these nurses were ex-
cluded from the analyses. Secondly, among nurses with-
out prior cancer, we extracted primary invasive breast
cancer diagnoses (ICD-10 codes C50), as the main out-
come, and any other cancer (other than non-melanoma
skin cancer) between cohort baseline (1st April 1993 or
1st April 1999) and 31st December 2012. Furthermore,
we extracted data on breast cancer subtype by estrogen
receptor (ER) and progesterone receptor (PR) status
from the clinical database of the Danish Breast Cancer
Cooperative Group. [21]
Statistical analyses
We used Cox proportional hazards regression with age
as the underlying time, to investigate the association be-
tween smoking and breast cancer in a crude model (age
adjusted as age is underlying time scale), and in a fully
adjusted model, adjusted for age at the time of recruit-
ment, birth cohort (1990–1934; 1935–1944; 1945–1949;
1950–1955), Body Mass Index (BMI) (<18.5 kg/m2;
18.5–25 kg/m2; 25–30 kg/m2; ≥30 kg/m2), alcohol use
(none; moderate (1–14 drinks/week); heavy (>15 drinks/
week)), leisure time physical activity (low; medium;
high), night shift work (yes; no), age at menarche (years),
parity (yes; no), number of children, age at first birth
(years), menopausal status (yes; no), HT use (never,
ever), and OC use (never; ever). The follow-up started
on the cohort baseline date (1st April 1993 or 1st April
1999) and ended at the date of breast cancer (event) or
other cancer diagnoses (except non-melanoma skin can-
cer), death, emigration, or December 31, 2012 (censor-
ing), whichever came first. We evaluated the effect of
active smoking status, duration, intensity, and onset in
separate models. We performed tests for trend by using
the ordered category, including the reference as a con-
tinuous variable in the Cox model. We checked for the
proportional hazards assumption for all smoking vari-
ables and confounders based on scaled Schoenfeld resid-
uals. [22] The effect modification of an association
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between smoking and breast cancer by menopausal status,
obesity, alcohol use, and HT use was evaluated by intro-
ducing interaction terms into the Cox model, and tested
by the Wald test. Finally, separate models were fit for sub-
types of breast cancer according to ER status (ER+; ER-)
and ER status combined with PR status (ER+/PR+; ER
+/PR-; ER−/PR-; ER−/PR+) as outcomes. Results were
presented as hazard ratios (HRs) and 95% confidence in-
tervals (CI). Analyses were performed in Stata 11.2.
The study was entirely based on a data from registers
and approved by the Danish Data Inspection Agency,
which by Danish law serving as ethical approval of
register-based research. Thus, no contact has been taken
with participating women, relatives or their practicing
doctors, and no consent was needed.
Results
Of the total 28,731 nurses in the Danish Nurse Cohort,
we excluded 4 due to inactive (emigrated) vital status
and 1924 with cancer diagnosis before cohort baseline,
and 4972 with missing information on one or more co-
variates. Of the 21,831 nurses in the main analyses 1162
developed breast cancer during the mean follow-up of
15.7 years or 342,538 person-years, with an incidence
rate of 339 per 100,000 person-years.
The mean age at baseline was 53.2 years, 56.7% of the
women were postmenopausal, 14.5% nulliparous, and
the mean age at 1st childbirth for parous women was
25.9 years (Table 1). Compared with women who
remained free of breast cancer, those who developed the
cancer were more likely to be nulliparious, postmeno-
pausal, obese, heavy alcohol drinkers, slightly physically
active and HT users, but less likely to work night shifts,
and use OC.
The majority of nurses (63.7%) were ever smokers at
cohort baseline, (33.7% current, 30.0% previous) whilst
36.3% never smokers. 38.3% of women who developed
breast cancer were current smokers at baseline, as com-
pared to 33.4% of women who were free of breast cancer
(Table 1). Mean duration of smoking in ever smokers
was 23.3 years, mean intensity 12.4 g/day or 16.0 pack-
years, and mean age at smoking initiation 20.4 years.
Smoking duration and intensity were higher in nurses
who developed breast cancer than in those who were
free of breast cancer. 62.8% of parous women and 68.9%
of nulliparous women were ever smokers. The majority
of women started smoking early, before 1st childbirth or
before age 21 (nulliparous women).
Whilst smoking rates and smoking intensity were
lower in younger, as compared to older birth cohorts,
the age at smoking initiation decreased, from 22.6 years
in women born before 1935, to 17.8 in women born
1950–55 (Table 2). Accordingly, number of women
smoking before 1st childbirth increased. Notably, also
the use of HT and alcohol was higher in younger than in
older birth cohorts.
Compared to never smokers, we found an increased risk
of breast cancer in ever (HR: 1.18; 95% CI: 1.04–1.34)
smokers, strongest in current (1.27; 1.11–1.46), and weaker
in previous (1.08; 0.94–1.26) smokers (Table 3). We found
a statistically significant dose-response association with in-
creasing smoking duration and intensity, with highest risk
of breast cancer observed in women smoking 21–20 years
(1.24; 1.06–1.46) and >30 years (1.21; 1.01–1.46), 11–15 g/
day (1.22; 1.02–1.46) and >15 g/day (1.31; 1.11–1.56), and
>20 pack-years (1.32; 1.12–1.55). Compared to parous
never smokers, the risk of breast cancer seemed weaker in
parous ever smokers who started smoking before (1.17;
1.02–1.34, results not shown) than after (1.28; 1.00–1.62)
1st childbirth. However, when accounting for smoking in-
tensity, we found the strongest association among parous
women who smoked heavily (>10 pack-years) before 1st
childbirth (1.58; 1.20–2.10) and weak in those who smoked
≤10 pack-years (1.13; 0.98–1.31). Nulliparous ever smokers
had also increased risk of breast cancer, similar to that ob-
served in parous women (1.21; 0.88–1.67, results not
shown), and slightly higher with late (≥ age 21) (1.29; 0.89–
1.88) than with early (< 21 years) (1.10; 0.76–1.58) onset of
smoking. When limiting analyses to the 12,376 women
who were postmenopausal at the time of recruitment, we
found that both women who started smoking before (1.20;
1.01–1.41) and after (1.66; 0.74–3.75) menopause had in-
creased risk of breast cancer. Finally, when considering
smoking intensity in different periods of life related to 1st
childbirth and menopause among 8347 parous postmeno-
pausal women, the strongest effect of smoking on breast
cancer was observed with smoking before 1st childbirth
(11–20 pack-years: 2.16; 1.45–3.20), and a weaker, but still
strong effect was seen for smoking between 1st childbirth
and menopause (> 20 pack-years: 1.84; 1.34–2.53), while
the weakest effects was seen for smoking after menopause
(> 20 pack-years: 1.29; 0.70–4.98).
No statistically significant interaction was found be-
tween smoking and menopausal status at the time of re-
cruitment, BMI, HT, or alcohol use (Table 4).
We found a slightly stronger association of smoking
with ER+ (1.17; 1.01–1.36) than with ER- (1.11; 0.81–1.53)
breast cancer, compared to never smoking (Table 5).
When considering ER together with PR status, we found
strongest associations of ever smoking with ER+/PR-
breast cancer (1.75; 1.12–2.71), weaker with ER+/PR+
breast cancer (1.27; 1.02–1.59), and none with ER−/PR-
(1.08; 0.72–1.611) or ER−/PR- (1.02; 0.26–4.07) breast
cancer (Table 5).
Discussion
In this Danish Nationwide cohort of female nurses we
found a positive association between active tobacco
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Table 1 Description of the Danish Nurse Cohort (n = 21,831) at the time of recruitment in 1993 or 1999 and by breast cancer status
during follow-up until 2013
Total
N = 21,831
Breast Cancer
N = 1162
No Breast Cancer
N = 20,669
Age
Mean (SD) age at baseline (years) 53.2 (8.0) 53.7 (7.6) 53.2 (8.1)
Birth Cohort
Born 1900–1934, n (%) 5179 (23.7) 295 (25.4) 4884 (23.6)
Born 1935–1944, n (%) 6707 (30.7) 428 (36.8) 6279 (30.4)
Born 1945–1949, n (%) 4564 (20.9) 244 (21.0) 4320 (20.9)
Born 1950–1955, n (%) 5381 (24.6) 195 (16.8) 5186 (25.1)
Reproductive Factors
Mean (SD) age at menarche 13.5 (1.5) 13.5 (1.5) 13.5 (1.5)
Nulliparous, n (%) 3170 (14.5) 189 (16.3) 2981 (14.4)
Mean (SD) number of children in parous women 2.3 (0.9) 2.3 (0.9) 2.3 (0.9)
Mean (SD) age at first birth in parous women 25.9 (4.0) 25.9 (4.0) 26.3 (4.1)
Postmenopausal, n (%) 12,376 (56.7) 696 (59.9) 11,680 (56.5)
Body Mass Index (BMI)
Mean (SD) BMI (kg/m2) 23.7 (3.5) 23.8 (3.5) 23.7 (3.5)
BMI < 18.5 kg/m2, n (%) 529 (2.4) 22 (1.9) 507 (2.5)
BMI 18.5–24.9 kg/m2, n (%) 15,070 (69.0) 819 (70.5) 14,251 (68.9)
BMI 25–29.9 kg/m2, n (%) 4979 (22.8) 245 (21.1) 4734 (22.9)
BMI ≥ 30 kg/m2, n (%) 1253 (5.7) 76 (6.5) 1177 (5.7)
Alcohol consumption
Does not drink alcohol, n (%) 3320 (15.2) 183 (15.7) 3137 (15.2)
Moderate drinker (1–14 drinks/week), n (%) 13,533 (62.0) 670 (57.7) 12,863 (62.2)
Heavy drinker (> 14 drinks/week), n (%) 4978 (22.8) 309 (26.6) 4669 (22.6)
Leisure time physical activity
Low physical activity, n (%) 1428 (6.5) 79 (6.8) 1349 (6.5)
Medium physical activity, n (%) 5905 (27.0) 298 (25.6) 5607 (27.1)
High physical activity, n (%) 14,498 (66.4) 785 (67.6) 13,713 (66.3)
Shift Work
Working night shifts, n (%) 967 (5.5) 45 (4.9) 922 (5.5)
Hormone Use
Ever used oral contraceptives, n (%) 12,701 (58.2) 663 (57.1) 12,038 (58.2)
Ever used hormone therapy, n (%) 5951 (27.3) 407 (35.0) 5544 (26.8)
Smoking Status
Never smoker, n (%) 7923 (36.3) 379 (32.6) 7544 (36.5)
Former smoker, n (%) 6557 (30.0) 338 (29.1) 6219 (30.1)
Current smoker, n (%) 7351 (33.7) 445 (38.3) 6906 (33.4)
Ever smoker, n (%) 13,908 (63.7) 783 (67.4) 13,125 (63.5)
Smoking Intensity
Mean (SD) smoking durationa (years) 23.3 (12.2) 23.9 (11.7) 23.3 (12.2)
Mean (SD) smoking intensitya (g/day) 12.4 (8.3) 12.7 (8.0) 12.4 (8.3)
Mean (SD) pack-yearsa 16.0 (14.8) 16.6 (14.8) 15.9 (14.8)
Initiation of smoking
Mean age (SD) at smoking initiationa (years) 20.4 (5.5) 20.7 (5.7) 20.4 (5.5)
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smoking and breast cancer incidence in women older than
44 years, with the highest risk in women who smoked
heavily and for a long duration of time. The strongest risk
was detected in parous women who smoked heavily before
1st childbirth.
Our results confirmed the association between ac-
tive smoking and breast cancer incidence reported in
almost all recent prospective cohort studies. [6–13]
Albeit, the 27% increased breast cancer risk that we
found in current as compared to never smokers, was
stronger than the effects seen in any of the earlier
prospective studies. In other previous studies the risk
of breast cancer was reported to be increased by 24%
in both the American Cancer Society’s Cancer Pre-
vention Study II (CPS-II) [10] and the Women’s
Health Initiative (WHI) [7] studies; by 19% in the
Norwegian women [9]; by 15% in American retired
women [13]; by 8% in American Black Women’s
Health Study (BWHS) [8]; by 5% in American Nurses’
Health Study (NHS) [6]; and by 6% in the EPIC co-
hort. [11] We also found a strong effect of high
smoking intensity, with a 32% increased risk of breast
cancer risk in women smoking >20 pack-years; a risk
comparable to 34% increased risk observed in Norwe-
gian women smoking ≥16 pack-years, [9] but stronger
than effects found in any other study. [6–8, 11, 13]
The strong effects of smoking observed in both, our
and in the Norwegian cohorts (both that part of EPIC
study [11] .and the other Norwegian cohorts [9]) may
be explained by high prevalence, duration and inten-
sity of smoking in these Nordic cohorts with 34% of
the women being current smokers at the time of
recruitment as compared with 13% in American
nurses, [6] 8% in the American CPS-II study, [10]
and 6% in the WHI study. [7] The average number of
current smokers at the time of recruitment for the
European countries in the EPIC study was 20%. [11]
Furthermore, as we did not have data on passive
smoking, our estimates for smoking are likely under-
estimated, as the EPIC study found that excluding
passive smokers from the reference group led to
higher risk estimates for active smoking. [11]
Notably, no association between smoking and breast
cancer was found (current vs. never: 1.05; 0.72–1.54;
former vs. never: 1.00; 0.68–1.47) in the Danish Diet,
Cancer and Health cohort, which formed the Danish
part of the EPIC study. [11] A possible reason for the
difference between our results and those from Danish
EPIC cohort could be that the women in the cohorts
came from different birth cohorts. In the Danish EPIC
cohort, the majority of women were born before 1944,
and only 10% were born in 1945–1950. In the Danish
Nurse Cohort, half of the women were born in 1945–
1955 (Table 2). These younger birth cohorts started
smoking earlier and were able to accumulate more years
of smoking before the 1st childbirth than the older birth
cohorts: on average 7.8 years as compared to 5.3 years
(Table 2). The oldest generations in the Danish Nurse
Cohort furthermore included a high proportion of nul-
liparous women; 27% for nurses born in 1990–1934
(Table 2), reflecting that before the Second World War
Danish nurses were mostly unmarried. Finally, the EPIC
cohort might be affected by a “healthy worker effect”, as
the cohort members were recruited from general
Table 1 Description of the Danish Nurse Cohort (n = 21,831) at the time of recruitment in 1993 or 1999 and by breast cancer status
during follow-up until 2013 (Continued)
Initiation of smoking in 18,661 parous women
Parous never smoker 6938 (37.2) 326 (33.5) 6612 (37.4)
Parous ever smoker 11,723 (62.8) 647 (66.5) 11,076 (62.6)
Parous/around 1st birth or later, n (%) 1457 (6.7) 88 (7.6) 1369 (6.6)
Parous/before 1st childbirth, ≤ 10 pack-years, n (%) 9367 (42.9) 493 (42.4) 8874 (42.9)
Parous/before 1st childbirth, > 10 pack-years, n (%) 899 (4.1) 66 (5.7) 833 (4.0)
Initiation of smoking in 3170 nulliparous women
Nulliparous never smoker 985 (31.1) 53 (28.0) 932 (31.3)
Nulliparous ever smoker 2185 (68.9) 136 (72.0) 2049 (68.7)
Nulliparous, before age 21b years, n (%) 1264 (5.8) 74 (6.4) 1190 (5.8)
Nulliparous, age 21 years or later, n (%) 921 (4.2) 62 (5.3) 859 (4.2)
Initiation of smoking in 12,376 postmenopausal women
Postmenopausal never smoker, n (%) 3988 (32.2) 202 (29.0) 3786 (32.4)
Before menopause, n (%) 8301 (67.1) 488 (70.1) 7813 (66.9)
After menopause, n (%) 87 (0.7) 6 (0.9) 81 (0.7)
SD standard deviation; ain ever smokers. b21 is mean age of smoking initiation in the cohort
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Table 2 Description of the Danish Nurse Cohort (n = 21,831) at the time of recruitment in 1993 or 1993 and by birth cohort
Birth Cohort 1900–1934
N = 5179
1935–1944
N = 6707
1945–1949
N = 4564
1950–1955
N = 5381
Age
Mean (SD) age at baseline (years) 65.3 (5.8) 53.1 (3.0) 47.7 (1.9) 46.4 (1.5)
Reproductive Factors
Mean (SD) age at menarche 14.0 (1.5) 13.6 (1.6) 13.4 (1.5) 13.2 (1.5)
Nulliparous, n (%) 1401 (27.1) 764 (11.4) 431 (9.4) 574 (10.7)
Mean (SD) number of children in parous women 2.5 (1.0) 2.4 (0.9) 2.3 (0.8) 2.3 (0.8)
Mean (SD) age at first birth in parous women 27.9 (4.1) 25.7 (3.6) 25.0 (3.6) 25.6 (4.2)
Postmenopausal, n (%) 5170 (99.8) 5060 (75.4) 1240 (27.2) 906 (16.8)
Body Mass Index (BMI)
Mean (SD) BMI (kg/m2) 23.8 (3.5) 23.7 (3.4) 23.5 (3.4) 23.8 (3.6)
BMI < 18.5 kg/m2, n (%) 199 (3.8) 148 (2.2) 100 (2.2) 82 (1.5)
BMI 18.5–24.9 kg/m2, n (%) 3368 (65.0) 4657 (69.4) 3293 (72.2) 3752 (69.7)
BMI 25–29.9 kg/m2, n (%) 1315 (25.4) 1527 (22.8) 944 (20.7) 1193 (22.2)
BMI ≥ 30 kg/m2, n (%) 297 (5.7) 375 (5.6) 227 (5.0) 354 (6.6)
Alcohol consumption
Does not drink alcohol, n (%) 1278 (24.7) 980 (14.6) 516 (11.3) 546 (10.1)
Moderate drinker (1–14 drinks/week), n (%) 2900 (56.0) 4177 (62.3) 2923 (64.0) 3533 (65.7)
Heavy drinker (> 14 drinks/week), n (%) 1001 (19.3) 1550 (23.1) 1125 (24.6) 1302 (24.2)
Leisure time physical activity
Low physical activity, n (%) 467 (9.0) 392 (5.8) 250 (5.5) 319 (5.9)
Medium physical activity, n (%) 1090 (21.0) 1809 (27.0) 1406 (30.8) 1600 (29.7)
High physical activity, n (%) 3622 (69.9) 4506 (67.2) 2908 (63.7) 3462 (64.3)
Shift Work
Working night shifts, n (%) 191 (12.5) 453 (7.4) 178 (4.0) 145 (2.7)
Hormone Use
Ever used oral contraceptives, n (%) 2082 (40.2) 2490 (37.1) 779 (17.1) 600 (11.2)
Ever used hormone therapy, n (%) 1143 (22.1) 3544 (52.8) 3462 (75.9) 4552 (84.6)
Smoking status
Never smoker, n (%) 1481 (28.6) 2487 (37.1) 1840 (40.3) 2115 (39.3)
Former smoker, n (%) 1812 (35.0) 1716 (25.6) 1242 (27.2) 1787 (33.2)
Current smoker, n (%) 1886 (36.4) 2504 (37.3) 1482 (32.5) 1479 (27.5)
Ever smoker, n (%) 3698 (71.4) 4220 (62.9) 2724 (59.7) 3266 (60.7)
Smoking Intensity
Mean (SD) smoking durationa (years) 29.4 (14.5) 23.4 (11.3) 19.8 (9.5) 19.4 (9.2)
Mean (SD) smoking intensitya (g/day) 12.1 (9.0) 13.0 (8.8) 12.5 (7.5) 12.0 (7.5)
Mean (SD) pack-yearsa 19.5 (18.6) 16.9 (14.9) 13.5 (11.1) 12.8 (11.0)
Initiation of smoking
Mean age (SD) at smoking initiationa (years) 22.6 (6.9) 21.1 (5.3) 19.6 (3.9) 17.8 (3.3)
Initiation of smoking in 18,661 parous women
Parous never smoker, n (%) 1078 (28.5) 2246 (37.8) 1684 (40.8) 1930 (40.2)
Parous ever smoker, n (%) 2700 (71.5) 3697 (62.2) 2449 (59.3) 2877 (59.9)
Parous/around 1st birth or later, n (%) 430 (8.3) 632 (9.4) 259 (5.7) 136 (2.5)
Parous/before 1st childbirth, ≤ 10 pack-years, n (%) 2047 (39.5) 2824 (42.1) 2037 (44.6) 2459 (45.7)
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population and only 37% participated [23] as compared
to 86% participation rate in the Danish Nurse Cohort.
[18] While the percentage of never smokers was 36% in
the Danish Nurse Cohort, it was 43% in the Danish
EPIC cohort. [11]
We found the highest risk of breast cancer related to
smoking heavily before the 1st childbirth, in agreement
with existing evidence. [6–8, 10–12] Breast development
with increased epithelial cell proliferation begins before
the menarche, [24] while the terminal differentiation of
the breast epithelium takes place in the last trimester of
pregnancy. [25] It is therefore plausible that the time be-
fore the 1st pregnancy may be critical for susceptibility to
tobacco smoke carcinogens. In contrast to the EPIC study,
[11] no protective effect of smoking in postmenopausal
age was found in either American [6] or Danish nurses.
As alcohol is an established risk factor for breast
cancer, and as alcohol and smoking often come to-
gether, the possible confounding by alcohol of the ef-
fect of smoking on the risk of breast cancer has been
debated in literature. Alcohol has also been previously
shown to be an independent risk factor for breast
cancer in the Danish Nurse Cohort. [26] However, al-
cohol did not seem to be a confounder in our study.
Our risk estimates were adjusted for intensity of alco-
hol consumption. The breast cancer risk was some-
what enhanced in heavy drinking current smokers,
but, in line with the results of the EPIC study, [11]
the trend of increase in risk of smoking by increasing
level of alcohol consumption was not statistically sig-
nificant neither for ever nor for current smokers
(Table 4). The available data thus indicate that the ef-
fect of smoking on breast cancer risk is independent
of the effect of alcohol.
We contribute with novel data on smoking and subtypes
of breast cancer, as only a few studies have previously in-
cluded this information. [7, 10, 11, 13] We detected a very
strong association between current (vs. never) smoking
and ER+/PR- breast cancer (1.92; 1.19–3.10), followed by
a weaker but robust association with ER+/PR+ breast can-
cer (1.36; 1.06–1.76), and none for ER−/PR- or ER−/PR+
breast cancers. This is in agreement with EPIC study,
which reported the strongest risk related to current smok-
ing of 34% for ER+/PR-, 23% for ER+/PR+, and 13% for
ER−/PR-, [11] and American Retired women study which
found 37% increased risk of ER+/PR- breast cancer in
current smokers, and none with ER+/PR+ or ER−/PR-
subtypes. [13] Luo et al. has reported a 28% increased risk
of ER+/PR+ breast cancer in current compared to never
smoker, but in contrast to our study and current literature,
none with ER+/PR- or ER−/PR-, [7] whereas Gaudet et al.
reported association with smoking limited to ER+ breast
cancer subtype, and none with ER-, but lacked data on PR
status. [10]
Strengths of this study include data from a large pro-
spective nationwide cohort with comprehensive follow-
up of both vital status and incident breast cancer cases
from linkage with nationwide registers. Exposure infor-
mation from the cohort was expected to be valid as
already known associations between breast cancer and,
for instance, alcohol use [26] and HT [26–28] have
already been documented in this cohort. Another
strength was the high smoking prevalence, where 34%
of women in our cohort were current smokers. This
means that potential confounding not controlled for will
affect our results less than is the case in the studies
where smokers constitute a smaller, and thus a more
marginalized group of women.
The main limitation was the exposure misclassification
as the smoking exposure was based on questionnaires at
the time of recruitment, without follow-up, and the lack
of information on passive tobacco smoke. However,
prevalence of active and passive smoking in Denmark in
this period was high, and based on data from a related
Table 2 Description of the Danish Nurse Cohort (n = 21,831) at the time of recruitment in 1993 or 1993 and by birth cohort
(Continued)
Parous/before 1st childbirth, > 10 pack-years, n (%) 223 (4.3) 241 (3.6) 153 (3.4) 282 (5.2)
Initiation of smoking in 3170 nulliparous women
Nulliparous never smoker, n (%) 403 (28.8) 241 (31.5) 156 (36.2) 185 (32.2)
Nulliparous ever smoker, n (%) 998 (71.2) 523 (68.5) 275 (63.8) 389 (67.8)
Nulliparous, before age 21b years, n (%) 442 (8.5) 295 (4.4) 187 (4.1) 340 (6.3)
Nulliparous, age 21 years or later, n (%) 556 (10.7) 228 (3.4) 88 (1.9) 49 (0.9)
Initiation of smoking in 12,376 postmenopausal women
Postmenopausal never smoker, n (%) 1477 (28.6) 1757 (34.7) 454 (36.6) 300 (33.1)
Postmenopausal ever smoker, n (%) 3693 (71.4) 3303 (65.3) 786 (63.4) 606 (66.9)
Before menopause, n (%) 3633 (70.3) 3281 (64.8) 782 (63.1) 605 (66.8)
After menopause, n (%) 60 (1.2) 22 (0.4) 4 (0.3) 1 (0.1)
SD standard deviation; ain ever smokers. b21 is mean age of smoking initiation in the cohort
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Table 3 Association between active smoking and breast cancer in 21,831 women in the Danish Nurse Cohort
N Person-
years
No.
of
cases
Age adjusted Fullya adjusted
HR (95% CI) HR (95% CI)
Never smoked (ref.) 7923 126,950 379 1.00 1.00
Former smoker 6557 102,190 338 1.11 (0.96–1.29) 1.08 (0.94–1.26)
Current smoker 7351 113,400 445 1.32 (1.15–1.51) 1.27 (1.11–1.46)
Ever smokers 13,908 215,589 783 1.22 (1.08–1.38) 1.18 (1.04–1.34)
Smoking duration among ever smokers
≤ 10 years 2925 47,335 156 1.10 (0.92–1.33) 1.10 (0.91–1.33)
11–20 years 3175 50,151 175 1.17 (0.98–1,40) 1.15 (0.96–1.38)
21–30 years 4456 68,818 259 1.26 (1.08–1.48) 1.24 (1.06–1.46)
> 30 years 3295 49,285 193 1.32 (1.11–1.57) 1.21 (1.01–1.46)
p-value for trend 0.004
Every increase of 10 years 1.08 (1.04–1.12) 1.06 (1.02–1-11)
Smoking (Tobacco) Intensity among ever smokers
> 6 g/day 3098 49,245 161 1.10 (0.91–1.32) 1.07 (0.89–1.29)
6–10 g/day 4317 67,410 235 1.17 (0.99–1.38) 1.14 (0.97–1.34)
11–15 g/day 3050 46,962 175 1.25 (1.05–1.50) 1.22 (1.02–1.46)
> 15 g/day 3443 51,973 212 1.37 (1.16–1.62) 1.31 (1.11–1.56)
p-value for trend 0.001
Every increase of 10 g/day 1.05 (0.97–1.14) 1.04 (0.95–1.13)
Lifetime pack-years
≤ 10 pack-years 6082 96,640 327 1.13 (0.98–1.31) 1.12 (0.97–1.30)
11–20 pack-years 3536 54,993 192 1.17 (0.99–1.39) 1.14 (0.96–1.36)
> 20 pack-years 4290 63,956 264 1.39 (1.19–1.63) 1.32 (1.12–1.55)
p-value for trend 0.002
Every increase of 20 pack-years 1.10 (1.01–1.20) 1.07 (0.98–1.18)
Initiation of smoking in 18,661 parous women
Parous never smoker (ref.) 6938 111,811 326 1.00 1.00
Parous, around first birth or later 1457 23,553 88 1.28 (1.01–1.62) 1.28 (1.00–1.62)
Parous, before first childbirth, ≤ 10 pack-years 9367 146,965 493 1.15 (1.00–1.33) 1.13 (0.98–1.31)
Parous, before first childbirth, > 10 pack-years 899 12,901 66 1.77 (1.36–2-31) 1.58 (1.20–2.10)
Initiation of smoking in 3170 nulliparous women
Nulliparous never smoker (ref.) 985 15,138 53 1.00 1.00
Nulliparous, before age 21b years 1264 18,737 74 1.14 (0.80–1.62) 1.10 (0.76–1.58)
Nulliparous, age 21 years or later 921 13,434 62 1.31 (0.91–1.90) 1.29 (0.89–1.88)
Initiation of smoking in 12,376 postmenopausal women
Postmenopausal never smoker (ref.) 3988 66,617 202 1.00 1.00
Before menopause 8301 130,987 488 1.23 (1.05–1.45) 1.20 (1.01–1.41)
After menopause 87 1252 6 1.60 (0.71–3.59) 1.66 (0.74–3.75)
Pack-years in 8347 parous postmenopausal womenc
Parous postmenopausal never smoker (ref.) 2712 129 1.00 1.00
Pack-years before 1st childbirthd
≤ 10 pack-years 4349 70,627 227 1.16 (0.93–1.44) 1.14 (0.92–1.42)
11–20 pack-years 366 5233 34 2.36 (1.62–3.45) 2.16 (1.45–3.20)
> 20 pack-years 61 854 4 1.69 (0.63–4.59) 1.38 (0.50–3.78)
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Danish Diet, Cancer and Health cohort recruited in the
same period, we estimated earlier that only 5% of
women in this period were not exposed to passive
smoke at home or work. [29] In any case, passive smok-
ing is difficult to assess accurately, due to its ubiquitous
exposure, and the American nurses study failed to find
an association between passive smoking and breast can-
cer, [6] while the EPIC study found that excluding pas-
sive smokers from the reference group led to higher risk
estimates for active smoking. [11]
Danish nurses have been found to live a generally
healthier lifestyle than a representative sample of Danish
women, as they smoked less and had higher physical
activity levels, although they consumed more alcohol.
[18] Furthermore, there was no major differences be-
tween Danish nurses and Danish women in general
with respect to use of health care and disease occur-
rence. [18] It is therefore reasonable to generalize the
findings based on the Danish Nurses Cohort to Danish
women in general.
Table 3 Association between active smoking and breast cancer in 21,831 women in the Danish Nurse Cohort (Continued)
p-value for trend 0.006
Pack-years from 1st childbirth until menopaused
≤ 10 pack-years 2572 42,484 128 1.08 (0.85–1.38) 1.03 (0.81–1.33)
11–20 pack-years 1606 25,391 79 1.12 (0.85–1.49) 1.13 (0.85–1.50)
> 20 pack-years 817 12,471 60 1.74 (1.28–2.36) 1.84 (1.34–2.53)
p-value for trend 0.029
Pack-years after menopaused
≤ 10 pack-years 2294 37,270 124 1.20 (0.94–1.53) 1.19 (0.93–1.53)
11–20 pack-years 453 6695 20 1.09 (0.68–1.74) 1.03 (0.64–1.66)
> 20 pack-years 1966 32,094 118 1.32 (1.03–1.70) 1.29 (0.70–4.98)
p-value for trend 0.412
HR hazard ratio, CI confidence interval aAdjusted for age, no of births, Body Mass Index, physical activity, alcohol use, oral contraceptive use, age at menarche,
menopause, age at 1st birth, parity, number of birth, hormone therapy use, and night shift work. b21 is mean age at 1st childbirth in this cohort; c with
information on age at cessation of menstrual bleeding; d every increase of 20 pack-years
Table 4 Effect modification of association between active smoking and breast cancer in 21,831 women in the Danish Nurse Cohort
by menopausal status, obesity, alcohol consumption and hormone therapy use
Never Former Current Ever
N No. of cases HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Menopausal status
Premenopausal 9455 466 1.00 1.03 (0.82–1.29) 1.30 (1.04–1.61) 1.16 (0.95–1.40)
Postmenopausal 12,376 696 1.00 1.12 (1.92–1.37) 1.27 (1.05–1.52) 1.20 (1.02–1.42)
p-value 0.77 0.80
BMI
Not obese (< 30 kg/m2) 20,578 1086 1.00 1.07 (0.92–1.25) 1.25 (1.08–1.45) 1.11 (1.03–1.33)
Obese (≥ 30 kg/m2) 1253 76 1.00 1.23 (0.72–2.09) 1.47 (0.81–2.66) 1.32 (0.82–2.12)
p-value 0.84 0.63
Alcohol Consumption
None 3320 183 1.00 1.11 (0.77–1.61) 1.17 (0.83–1.66) 1.14 (0.85–1.54)
Moderate (1–14 drinks/week) 13,533 670 1.00 1.13 (0.94–1.37) 1.26 (1.05–1.52) 1.19 (1.02–1.40)
Heavy (>14 drinks/week) 4978 309 1.00 0.96 (0.70–1.31) 1.34 (1.01–1.77) 1.17 (0.90–1.52)
p-value 0.66 0.99
Hormone therapy use
Never 15,880 755 1.00 1.05 (0.88–1.26) 1.21 (1.02–1.44) 1.13 (0.97–1.32)
Ever 5951 407 1.00 1.15 (0.88–1.49) 1.36 (1.06–1.73) 1 26 (1.01–1.58)
p-value 0.63 0 33
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Conclusion
In this cohort of Danish nurses, we found the risk of
breast cancer to be almost 30% increased in current
smokers as compared with never smokers. The risk in-
creases both with smoking duration and smoking inten-
sity. The highest risk was seen in women with more
than 10 pack-years of smoking before the birth of their
first child. We found no protective effect of smoking in
post-menopausal age. The study contributed to the accu-
mulating evidence for smoking - in particular in early
life – as causally associated with an increased risk of
breast cancer.
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